The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khommyatov M.R.

Central State Medical Academy

Smolentseva I.G.

Russian Medical Academy of Continuous Professional Education

Golubev S.A.

Central State Medical Academy;
Gannushkin Psychiatric Clinical Hospital No. 4;
Mental Health Research Center

Goryunov A.V.

Mental Health Research Center

Samushiya M.A.

Central State Medical Academy

Clinical presentation and diagnosis of Parkinson’s disease in patients with schizophrenia spectrum disorders

Authors:

Khommyatov M.R., Smolentseva I.G., Golubev S.A., Goryunov A.V., Samushiya M.A.

More about the authors

Read: 1687 times


To cite this article:

Khommyatov MR, Smolentseva IG, Golubev SA, Goryunov AV, Samushiya MA. Clinical presentation and diagnosis of Parkinson’s disease in patients with schizophrenia spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):73‑80. (In Russ.)
https://doi.org/10.17116/jnevro202412411173

Recommended articles:
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
Neuroinflammatory and neurodegenerative aspe­cts of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):102-111
Schi­zophrenic spectrum diso­rders and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):136-141
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14

References:

  1. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). 2017;124(8):901-905.  https://doi.org/10.1007/s00702-017-1686-y
  2. Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has parkinson’s disease: The Spouse’s perspective by stage of disease. Movv Disord. 1998;13:20-28.  https://doi.org/10.1002/mds.870130108
  3. Rothenberg KG, Rajaram R. Advances in management of psychosis in neurodegenerative diseases. Curr Treat Options Neurol. 2019;21(1):3.  https://doi.org/10.1007/s11940-019-0545-6
  4. Goetz CG, Stebbins GT, Ouyang B. Visual plus nonvisual hallucinations in Parkinson’s disease: Development and evolution over 10 years. Mov Disord. 2011;26(12):2196-2200. https://doi.org/10.1002/mds.23835
  5. Chou K, Messing S, Oakes D, et al. Drug-Induced Psychosis in Parkinson Disease Phenomenology and Correlations Among Psychosis Rating Instruments. Clin Neuropharmacol. 2005;29(1):59.  https://doi.org/10.1097/00002826-200601000-00014
  6. Caldani S, Amado I, Bendjemaa N, et al. Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia. Psychiatry Res. 2017;256:490-497.  https://doi.org/10.1016/j.psychres.2017.06.01
  7. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med. 2009;39:1065-1076. https://doi.org/10.1017/S0033291708004716
  8. Martin L, Stein K, Kubera K, et al. Movement markers of schizophrenia: a detailed analysis of patients’ gait patterns. Eur Arch Psychiatry Clin Neurosci. 2022;272(7):1347-1364. https://doi.org/10.1007/s00406-022-01402-y
  9. Presta V, Paraboschi F, Marsella F, et al. Posture and gait in the early course of schizophrenia. PLoS ONE. 2021;16(1):e0245661. https://doi.org/10.1371/journal.pone.0245661
  10. Kim K, Kim S, Myung W, et al. Shared Genetic Background between Parkinson’s Disease and Schizophrenia: A Two-Sample Mendelian Randomization Study. Brain Sci. 2021;11(8):1042. https://doi.org/10.3390/brainsci11081042
  11. Nalls MA, Saad M, Noyce AJ, et al. Genetic comorbidities in Parkinson’s disease. Hum Mol Genet. 2014;23(3):831-841.  https://doi.org/10.1093/hmg/ddt465
  12. Kuusimäki T, Al-Abdulrasul H, Kurki S, et al. Increased Risk of Parkinson’s Disease in Patients With Schizophrenia Spectrum Disorders. Mov Disord. 2021;36(6):1353-1361. https://doi.org/10.1002/mds.28484
  13. Gabilondo A, Alonso-Moran E, Nuño-Solinis R, et al. Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. J Psychosom Res. 2017;93:102-109.  https://doi.org/10.1016/j.jpsychores.2016.12.011
  14. Smith DJ, Langan J, McLean G, et al. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. 2013;3(4):e002808. https://doi.org/10.1136/bmjopen-2013-002808
  15. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders. 2015;30(12):1591-1601. https://doi.org/10.1002/mds.26424
  16. Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med. 2003;3;348(14):1356-1364. https://doi.org/10.1056/NEJM2003ra020003
  17. Katunina EA, Bezdol’nyĭ IuN. Epidemiology of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(12):81-88. (In Russ.).
  18. Rossi M, Perez-Lloret S, Merello M. How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson’s disease? Parkinsonism Relat Disord. 2021;92:53-58.  https://doi.org/10.1016/j.parkreldis.2021.10.016
  19. Vaiman EE, Shnaider NA, Neznanov NG, Nasyrova RF. Drug-induced parkinsonism. Social and Clinical Psychiatry. 2021;31(1):96-103. (In Russ.). https://doi.org/10.31363/2313-7053-2021-57-4-15-35
  20. Levin OS, Shindriaeva NN, Anikina MA. Drug-induced parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(8):76-81. (In Russ.).
  21. Waddington JL. Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges. Acta Pharmacol Sin. 2020;41(4):464-470.  https://doi.org/10.1038/s41401-020-0373-y
  22. Vlaar AM, de Nijs T, Kessels AG, et al. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Eur Neurol. 2008;59:258e66. https://doi.org/10.1159/000115640
  23. Brigo F, Erro R, Marangi A, et al. Differentiating drug-induced parkinsonism from Parkinson’s disease: An update on non-motor symptoms and investigations. Parkinsonism Relat Disord. 2014;20(8):808-814.  https://doi.org/10.1016/j.parkreldis.2014.05.011
  24. Zahodne LB, Fernandez HH. Pathophysiology and treatment of psychosis in Parkinson’s disease: a review. Drugs Aging. 2008;25(8):665-682.  https://doi.org/10.2165/00002512-200825080-00004
  25. De Jong MH, Zemel D, Van Gool AR. Clinical Aspects of Co-Morbid Schizophrenia and Idiopathic Parkinson»s Disease. Clin Schizophr Relat Psychoses. 2014;8(1):36-40.  https://doi.org/10.3371/CSRP.DEZE.012513
  26. Ragimova AA, Samushiya MA, Ivolgin AF, Smolentseva IG. Neuropsychic symptoms of Parkinson’s disease in premotor stage. Kremlin medicine. Clinical Bulletin. 2019;4:45-56. (In Russ.). https://doi.org/10.26269/qbn4-g055
  27. Samushiya MA, Ragimova AA, Smolentseva IG, et al. Affective disorders in the onset of Parkinson’s disease. Clinical case. A clinical case. Kremlin medicine. Clinical Bulletin. 2019;4:160-167. (In Russ.). https://doi.org/10.26269/qkae-2f63
  28. Morleya JF, Dudab JE. Use of Hyposmia and Other Non-Motor Symptoms to Distinguish between Drug-Induced Parkinsonism and Parkinson’s Disease. J Parkinsons Dis. 2014;4(2):169-173. 
  29. Marsh L. Psychosis in Parkinson’s Disease. Current Treatment Options. Neurology. 2004; 6(3):181-189.  https://doi.org/10.1007/s11940-004-0010-y
  30. Buoli M, Caldiroli A, Altamura AC. Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders. J Geriatr Psychiatry Neurol. 2016;29(2):729.  https://doi.org/10.1177/0891988715606233

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.